Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

Among patients with chronic rhinosinusitis, higher IL-6 and IL-8 levels had links to decreases in several cognitive function ...

In fall 2024, xanomeline trospium chloride (XT) was approved by the U.S. Food and Drug Administration for the treatment of ...

Mental health issues are common in people with traumatic brain injury (TBI) and can continue for years. They may be related ...

A new study published in the Journal of Psychopharmacology has revealed that the way caffeine impacts your thinking skills is ...

Cognition Therapeutics (NASDAQ:CGTX – Get Free Report)‘s stock had its “buy” rating restated by equities research analysts at Chardan Capital in a note issued to investors on Wednesday,Benzinga ...

To mimic human cognitive processes, the study introduces a thinking method based on a built-in chain of thought (COT). This ...

NFL teams use the test to measure how quickly the brain can process information. But its emergence has not come without ...

The free exhibit shares stories of the violins that survived a period of hate and violence, and asks you to reflect on how present and past connect.

Cognition Therapeutics (CGTX) reported a positive outcome of an analysis of masked data from the ongoing ‘MAGNIFY’ Phase 2 trial of zervimesine ...